Randomized Phase Ⅲ Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small …

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Randomized Phase Ⅲ Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small …
この記事を読む
Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung …
この記事を読む
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis. Amrane KESMO Ope…
この記事を読む
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. Forde PM et al.N Engl J Med. 2025 Jun 2. E…
この記事を読む
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase Ⅲ Trial JCOG2…
この記事を読む
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-smal…
この記事を読む
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With…
この記事を読む
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy. Mountzios G et al.N Engl J Med. 2025 Jun 2.Epub …
この記事を読む
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell…
この記事を読む
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment:A Retrospective…